7-year-old Maverick has a rare genetic disorder that severely limits his vision. Now, a medication called Luxturna - the first gene therapy approved by the FDA - has the potential to substantially improve his sight, via an injection of a gene-carrying virus underneath his retina.
Watch more episodes of Prognosis here: [ Ссылка ]
#Prognosis #Technology
--------
Like this video? Subscribe to Bloomberg on YouTube: [ Ссылка ]
Become a Quicktake Member for exclusive perks: [ Ссылка ]
Bloomberg is the First Word in business news, delivering breaking news & analysis, up-to-the-minute market data, features, profiles and more: [ Ссылка ]
Connect with us on...
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
